![James Mulé](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Mulé
Direktor/Vorstandsmitglied bei
CG ONCOLOGY, INC.
Profil
James J.
Mulé is currently an Independent Director at CG Oncology, Inc. since 2018, a Director at Moffitt Technologies Corp.
since 2009, Executive Vice President at Translational Research In Oncology, and an Advisor at ORI Capital Ltd. Former positions include Director at Empower AI, Inc., Director-Tumor Immunology & Immunotherapy at the University of Michigan, Director at the National Cancer Institute, EVP & Associate Center Director at H.
Lee Moffitt Cancer Center & Research Institute, Inc., Independent Director at Fulgent Genetics, Inc. from 2016 to 2020, Adjunct Faculty at Stanford University, and Advisor at Select BioVentures LLC.
Education includes an undergraduate degree from New Jersey City University in 1974, a graduate degree from UW Medicine in 1977, and a doctorate from UW Graduate School.
Aktive Positionen von James Mulé
| Unternehmen | Position | Beginn |
|---|---|---|
| CG ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 22.10.2018 |
Moffitt Technologies Corp. | Direktor/Vorstandsmitglied | 01.01.2009 |
Translational Research In Oncology
 Translational Research In Oncology Miscellaneous Commercial ServicesCommercial Services Operates as an oncology clinical research organization | Corporate Officer/Principal | - |
ORI Capital Investment Advisory Hong Kong Ltd.
 ORI Capital Investment Advisory Hong Kong Ltd. Investment ManagersFinance ORI Capital invests in companies located across the globe. The firm targets companies operating in the fields of biotech with a focus on diagnostics, drug delivery, and therapeutics. It participates in early-stage transactions. | Berater | - |
Ehemalige bekannte Positionen von James Mulé
| Unternehmen | Position | Ende |
|---|---|---|
| FULGENT GENETICS, INC. | Direktor/Vorstandsmitglied | 27.05.2020 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Direktor/Vorstandsmitglied | - |
| NCI INC | Corporate Officer/Principal | - |
Select BioVentures LLC
 Select BioVentures LLC Investment ManagersFinance Select BioVentures focuses on investments in Florida-based and other bioscience companies. The firm seeks to invest in late pre-clinical and early clinical stage private or public biopharmaceutical, medical device and molecular diagnostic companies. | Berater | - |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ausbildung von James Mulé
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
42
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Empower AI, Inc.
 Empower AI, Inc. Packaged SoftwareTechnology Services Develops AI, information systems engineering, data management and information technology support services to federal agencies | Technology Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Jersey City University
 New Jersey City University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
 H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research & contributions to clinical trials, prevention and cancer control | Commercial Services |
CG Oncology, Inc.
 CG Oncology, Inc. BiotechnologyHealth Technology Operates as a late-stage clinical biopharmaceutical company focused on developing and commercializing backbone bladder-sparing therapeutic | Health Technology |
Select BioVentures LLC
Select BioVentures LLC Investment ManagersFinance Select BioVentures focuses on investments in Florida-based and other bioscience companies. The firm seeks to invest in late pre-clinical and early clinical stage private or public biopharmaceutical, medical device and molecular diagnostic companies. | Finance |
UW Medicine
 UW Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Translational Research In Oncology
Translational Research In Oncology Miscellaneous Commercial ServicesCommercial Services Operates as an oncology clinical research organization | Commercial Services |
Fulgent Genetics, Inc.
 Fulgent Genetics, Inc. Medical/Nursing ServicesHealth Services Provides genetic diagnostics services | Health Services |
Moffitt Technologies Corp. | |
UW Graduate School
 UW Graduate School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ORI Capital Investment Advisory Hong Kong Ltd.
ORI Capital Investment Advisory Hong Kong Ltd. Investment ManagersFinance ORI Capital invests in companies located across the globe. The firm targets companies operating in the fields of biotech with a focus on diagnostics, drug delivery, and therapeutics. It participates in early-stage transactions. | Finance |
